Progress in, and future prospects for, the treatment of primary pulmonary hypertension.
Wilkins
M R
MR
Wharton
J
J
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage; D016232:Endothelins / Q000037:antagonists & inhibitors; D011464:Epoprostenol / Q000008:administration & dosage; D005544:Forecasting; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000628:therapy*; D007262:Infusions, Intravenous
D000959:Antihypertensive Agents; D016232:Endothelins; D011464:Epoprostenol